Risk of acute kidney injury associated with the use of fluoroquinolones
Steven T. Bird(United States Food and Drug Administration), Joseph A. Delaney(Center for Drug Evaluation and Research), James M. Brophy(McGill University Health Centre), Mahyar Etminan(Oncolytics Biotech (Canada)), Abraham G. Hartzema(University of Florida)
Cited by 89
Related Papers
Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data
|BMJ|2017|525
Risk of venous thromboembolism in women with polycystic ovary syndrome: a population-based matched cohort analysis
|Canadian Medical Association Journal|2012|120
Isotretinoin and Risk for Inflammatory Bowel Disease
|JAMA Dermatology|2013|93
Remdesivir for the treatment of COVID-19: a systematic review and meta-analysis
|Clinical Microbiology and Infection|2022|89
Statin Use and Risk of Vascular Events Among Cancer Patients After Radiotherapy to the Thorax, Head, and Neck
|Journal of the American Heart Association|2019|87